 |
3rd Focused Meeting on PI3K signalling and disease
Bath Assembly Rooms, UK
6 - 8 November 2006
A Biochemical Society Focused Meeting
Proceedings (invited
speakers) will be published in Biochemical
Society Transactions.
Abstract Deadline: Monday 4
September 2006
Online
Abstract submission is now open.
Early Registration
Deadline: Friday 6 October 2006
After this date, an
additional late fee of ?0 will be added to the registration
fees.
Online
registration is now open.
Student
Travel Grants are available for this meeting.
Scientific Programme
- Organizers
- Bart Vanhaesebroeck (Ludwig Institute for Cancer
Research, UK)
- Brian Hemmings (Friedrich Miescher Institute for
Biomedical Research, Switzerland)
- Melanie Welham (University of Bath, UK)
- Stephen Ward (University of Bath, UK)
Timetable
PI3K immunology and inflammation
Monday 6 November 2006
- 8:00-10:00 Registration
- 10:00-10:15 Welcome and Introduction
- 10:15-10:45 Klaus Okkenhaug (The
Babraham Institute, UK)
- PI3K signalling in T cell activation, differentiation and
regulation
- 10:45-11:15 Doreen Cantrell (University
of Dundee, UK )
- The function of PI3K signalling pathways in T lymphocytes
- 11:15-11:45 Akira Suzuki (Akita
University, Japan)
- Functions of PTEN in paraneoplastic cells such as endothelil
cells and NKT cells
- 11:45-12:45 Lunch
- 12:45-13:15 Christian Rommel (Serono
International S.A., Geneva)
- 13:15-13:30 Craig Gerard (Harvard
Medical School, USA)
- T-helper polarization and PI-3 kinase Gamma
- 13:30-13:45 Selected oral communication
- 13:45-14:15 John Westwick (Novartis, UK)
- PI3-kinase isoforms and inflammatory diseases
- 14:15-14:30 Coffee/tea break
- 14:30-14:45 Selected oral communication
- 14:45-15:00 Selected oral communication
- 15:00-15:15 Selected oral communication
PI3K lipid functions and their turnover
Monday 6 November 2006
- 15:15-15:45 C. Peter Downes (University
of Dundee, UK)
- 15:45-16:00 Stephen Ward (University of
Bath, UK)
- 16:00-16:30 Takehiko Sasaki (Akita
University, Japan)
- Role of phosphoinositide phosphatase in neutrophil migration
- 18:00-21:00 Poster session
PI3K isoforms, regulation and cell biology
Tuesday 7 November 2006
- 9:00-9:30 Bart Vanhaesebroeck (Ludwig
Institute for Cancer Research, UK)
- 9:30-9:45 Selected oral communication
- 9:45-10:15 Emilio Hirsch (University of
Torino, Italy)
- 10:15-10:45 Coffee/tea break
- 10:45-11:15 Matthias Wymann (Centre of
Biomedicine, Switzerland)
- 11:15-11:30 John Doukas (TargeGen, USA)
- Isoform-selective PI3K inhibitors as novel therapeutics for
the treatment of acute myocardial infarction
- 11:45-12:15 Len Stephens (The Babraham
Institute, UK)
- 12:15-13:15 Lunch
- 13:15-13:45 Marco Falasca (University
College London, UK)
- Role of Class II PI 3-Kinase in cell signalling
- 13:45-14:00 Selected oral communication
- 14:00-14:15 Selected oral communication
- 14:15-14:45 Jonathan Backer (Albert
Einstein College of Medicine, USA)
- Regulation of class I and III PI3-kinases
- 14:45-15:15 Coffee/tea break
- 15:15-15:45 Peter Vogt (The Scripps
Research Institute, USA)
- Gain of Function in PI3K
- 15:45-16:15 Melanie Welham (University
of Bath, UK)
- PI3Ks and regulation of embryonic stem cell fate
- 16:15-16:30 Selected oral communication
- 16:30-16:45 Selected oral communication
- 16:45-17:00 Poster prize presentation
- 19:00-23:00 Meeting dinner incorporating
Civic Reception at the Roman Baths
PI3K downstream signalling
Wednesday 8 November 2006
- 9:00-9:30 Brian Hemmings (Friedrich
Miescher Institute for Biomedical Research, Switzerland)
- 9:30-9:45 Selected oral communication
- 9:45-10:15 George Thomas (University of
Cincinnati, US)
- 10:15-10:30 Coffee/tea break
PI3K structural studies, inhibitors and cancer
Wednesday 8 November 2006
- 10:30-11:00 Roger Williams (Medical
Research Council, Cambridge, UK)
- 11:00-11:15 Selected oral communication
- 11:15-11:30 Selected oral communication
- 11:30-12:00 Zachary Knight (University
of California, USA)
- 12:00-13:00 Lunch
- 13:00-13:30 Dario Alessi (University of
Dundee, UK)
- PTEN, LKB1 and Cancer
- 13:30-13:45 Selected oral communication
- 13:45-14:00 Selected oral communication
- 14:00-14:30 Paul Workman (Cancer
Research UK, London)
- 14:30-14:45 Coffee/tea break
- 14:45-15:15 Tom Crabbe (UCB, UK)
- Exploring the potential of PI3K inhibitors for inflammation
and oncology
- 15:15-15:45 Ana Carrera (National Centre
of Biotechnology, Madrid)
- 15:45-16:00 Summary and closing remarks
|
|
|
